Skip to content
Wenlo
Sign in
← Markets

Intuitive Surgical Inc.

Fredrik Widman (VP Corporate Controller) sells ISRG shares

4ISRGFiled Oct 26, 2026, 3:02 PM ET· Period Oct 23, 2026

AI-generated summary

VP Corporate Controller Fredrik Widman exercised options to acquire 4,047 shares of Common Stock for $927,345.42 and sold 4,047 shares of Common Stock for $1,834,124.28 at an average price of $453.21. Following these transactions, the insider directly held 1,026 shares of Common Stock. The transactions were executed under a Rule 10b5-1 trading plan.

Key facts

Insider
Fredrik Widman · VP Corporate Controller

Rule 10b5-1 plan

DateTransactionSharesPriceValueHeld afterOwnership
Oct 23, 2026M · exercise or conversion of a derivativeFootnotes F1+307$304.67$93,533.691,333Direct
Oct 23, 2026M · exercise or conversion of a derivativeFootnotes F1+307$229.39$70,422.731,640Direct
Oct 23, 2026M · exercise or conversion of a derivativeFootnotes F1+312$290.33$90,582.961,952Direct
Oct 23, 2026M · exercise or conversion of a derivativeFootnotes F1+406$347.42$141,051.182,358Direct
Oct 23, 2026M · exercise or conversion of a derivativeFootnotes F1+406$245.60$99,713.602,764Direct
Oct 23, 2026M · exercise or conversion of a derivativeFootnotes F1+567$242.34$137,404.913,331Direct
Oct 23, 2026M · exercise or conversion of a derivativeFootnotes F1+567$177.99$100,918.463,898Direct
Oct 23, 2026M · exercise or conversion of a derivativeFootnotes F1+262$166.62$43,655.304,160Direct
Oct 23, 2026M · exercise or conversion of a derivativeFootnotes F1+263$182.83$48,085.164,423Direct
Oct 23, 2026M · exercise or conversion of a derivativeFootnotes F1+325$174.26$56,633.434,748Direct
Oct 23, 2026M · exercise or conversion of a derivativeFootnotes F1+325$139.52$45,344.005,073Direct
Oct 23, 2026S · open-market saleFootnotes F1, F2−4,047$453.21$1,834,124.281,026Direct
Oct 23, 2026M · exercise or conversion of a derivativeNon-Qualified Stock Option (right to buy)Footnotes F1, F3−325$0.00$0.00650Direct
Oct 23, 2026M · exercise or conversion of a derivativeNon-Qualified Stock Option (right to buy)Footnotes F1, F4−262$0.00$0.00524Direct
Oct 23, 2026M · exercise or conversion of a derivativeNon-Qualified Stock Option (right to buy)Footnotes F1, F4−325$0.00$0.00650Direct
Oct 23, 2026M · exercise or conversion of a derivativeNon-Qualified Stock Option (right to buy)Footnotes F1, F5−567$0.00$0.001,134Direct
Oct 23, 2026M · exercise or conversion of a derivativeNon-Qualified Stock Option (right to buy)Footnotes F1, F3−263$0.00$0.00526Direct
Oct 23, 2026M · exercise or conversion of a derivativeNon-Qualified Stock Option (right to buy)Footnotes F1, F6−307$0.00$0.00828Direct
Oct 23, 2026M · exercise or conversion of a derivativeNon-Qualified Stock Option (right to buy)Footnotes F1, F4−567$0.00$0.001,134Direct
Oct 23, 2026M · exercise or conversion of a derivativeNon-Qualified Stock Option (right to buy)Footnotes F1, F5−406$0.00$0.00812Direct
Oct 23, 2026M · exercise or conversion of a derivativeNon-Qualified Stock Option (right to buy)Footnotes F1, F5−312$0.00$0.00624Direct
Oct 23, 2026M · exercise or conversion of a derivativeNon-Qualified Stock Option (right to buy)Footnotes F1, F7−307$0.00$0.00828Direct
Oct 23, 2026M · exercise or conversion of a derivativeNon-Qualified Stock Option (right to buy)Footnotes F1, F4−406$0.00$0.00812Direct
Footnotes
  1. F1 The transaction took place in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on September 15, 2027.
  2. F2 The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $444.44 to $458.02 as follows: 40 shares sold at $444.44; 120 shares sold at $445.55 to $446.44; 80 shares sold at $446.76; 120 shares sold at $448.14 to $448.37; 200 shares sold at $449.30 to $450.22; 80 shares sold at $450.34 to $451.17; 1,447 shares sold at $451.98 to $452.97; 480 shares sold at $453.01 to $453.84; 360 shares sold at $454.02 to $455.00; 400 shares sold at $455.27 to $455.78; 480 shares sold at $456.33 to $457.19; and 240 shares sold at $457.42 to $458.02. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
  3. F3 Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. The option vests 1/8th six months after the date of grant and 1/48th monthly thereafter.
  4. F4 Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. Option shall vest 7/48 one month after the date of grant and 1/48 each month thereafter.
  5. F5 Non-statutory stock option granted pursuant to the 2010 Incentive Awards Plan. The option vests 1/8th six months after the date of grant and 1/48th monthly thereafter.
  6. F6 12.5% of the shares subject to the option vest on the six-month anniversary measured from February 10, 2023, and 1/48th of the total number of shares vest in forty-two (42) successive and equal monthly installments thereafter, subject to Reporting Person's continuous service to the Issuer through each such vesting date.
  7. F7 7/48th of the shares subject to the option vest on the one-month anniversary measured from August 10, 2023, and 1/48th of the total number of shares vest in forty-one (41) successive and equal monthly installments thereafter, subject to Reporting Person's continuous service to the Issuer through each such vesting date.

More ISRG filings

Not investment advice. Summaries can contain errors; the SEC filing is the official record.